1.5 mg retatrutide Vial Buy Retatrutide in the UK

Therefore, DPP-4 inhibitors may have pleiotropic effects

The serious risks are not common, but they are real and they matter

A clinical assessment can help you figure out whether GLP-1 therapy makes sense on its own or alongside other treatments

& Wu, L

Image Credit: azimmytws / Shutterstock.com A recent BMJ study determines whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists by type 2 diabetes (T2D) patients increases the risk of self-harm, suicidal ideation, and suicide as compared to patients prescribed dipeptidyl peptidase-4 (DPP-4) or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

Zheng, W., Pan, H., Wei, L., Gao, F